Roscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients' pretreatment status. [electronic resource]
Producer: 20080131Description: 1286-8 p. digitalISSN:- 1592-8721
- Aged
- Aged, 80 and over
- Alemtuzumab
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- administration & dosage
- Antigens, CD -- metabolism
- Antigens, Neoplasm -- metabolism
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- CD52 Antigen
- Cohort Studies
- Drug Synergism
- Female
- Glycoproteins -- metabolism
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Purines -- administration & dosage
- Roscovitine
- Salvage Therapy
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.